Sheridan, B C <br/><br/>
KATP channels contribute to beta- and adenosine receptor-mediated pulmonary vasorelaxation.  [electronic resource] 

 -  The American journal of physiology  11 1997 
 - L950-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0002-9513 
<br/><br/><label>Standard No.: </label>10.1152/ajplung.1997.273.5.L950  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP-Binding Cassette Transporters<br/>Acetylcholine--pharmacology<br/>Adenosine--pharmacology<br/>Adenylyl Cyclases--metabolism<br/>Animals<br/>Colforsin--pharmacology<br/>Cromakalim--pharmacology<br/>Cyclic AMP--metabolism<br/>Cyclic GMP--metabolism<br/>Glyburide--pharmacology<br/>In Vitro Techniques<br/>Isoproterenol--pharmacology<br/>KATP Channels<br/>Kinetics<br/>Male<br/>Muscle Relaxation--drug effects<br/>Muscle, Smooth, Vascular--drug effects<br/>Nitroprusside--pharmacology<br/>Potassium Channels--physiology<br/>Potassium Channels, Inwardly Rectifying<br/>Pulmonary Artery--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Adrenergic, beta--drug effects<br/>Receptors, Purinergic P1--drug effects<br/>Tolbutamide--pharmacology<br/>Vasodilation--drug effects